Circulate
United States
- Seattle, Washington
- 04/07/2025
- Seed
- $12,000,000
We are pioneering technologies and treatments to reverse aging and improve health outcomes. Rigorous scientific research is at the core of what we do. We are committed to innovating how people live healthier and longer lives by centering our approach on extensive research and clinical trials. Therapeutic Plasma Exchange (TPE) by Circulate is an evidence-based treatment that removes toxic, inflammatory, disease-causing and age-accelerating substances from the bloodstream. Our patented flagship product is improving lives today.
- Industry Outpatient Care Centers
- Website https://www.circulate.health/
- LinkedIn https://www.linkedin.com/company/circulatehealth/
Related People
Brad YounggrenFounder
United States -
Seattle, Washington
CEO & Co-founder, Circulate
Previous Roles:
President (98point6)
Chief Medical Officer (4x) (98point6, Cue Health, Shift Labs, Mobisante)
Board Member Eastside Research Associates, Cardiogenics
Current Advisory Board: TBD Health, Violett , AlliConnect, Calmwave, 98point6
Previous Advisory role: Crescent Health (acquired) Blumio (acquired), Highway 1, Cue Med, Misceo
Emergency Physician
Simple AI | $14,000,000 | (Feb 12, 2026)
Hubbl Technologies | $6,000,000 | (Feb 12, 2026)
Trener Robotics (formerly T-ROBOTICS) | $32,000,000 | (Feb 12, 2026)
Complyance | $20,000,000 | (Feb 12, 2026)
Brandlight | $30,000,000 | (Feb 12, 2026)
Tenna Systems | $13,500,000 | (Feb 12, 2026)
GitGuardian | $50,000,000 | (Feb 12, 2026)
Inertia | $450,000,000 | (Feb 12, 2026)
Electric Twin | $14,000,000 | (Feb 12, 2026)
Birch Hill Holdings | $2,500,000 | (Feb 12, 2026)
Smart Bricks | $5,000,000 | (Feb 12, 2026)
Scala | $8,500,000 | (Feb 12, 2026)